MA39449A1 - Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci - Google Patents
Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ciInfo
- Publication number
- MA39449A1 MA39449A1 MA39449A MA39449A MA39449A1 MA 39449 A1 MA39449 A1 MA 39449A1 MA 39449 A MA39449 A MA 39449A MA 39449 A MA39449 A MA 39449A MA 39449 A1 MA39449 A1 MA 39449A1
- Authority
- MA
- Morocco
- Prior art keywords
- optically active
- salts
- obtaining enantiomers
- pirlindole
- active pirlindole
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title abstract 2
- IWVRVEIKCBFZNF-UHFFFAOYSA-N LSM-1636 Chemical compound C1CNC2CCCC3=C2N1C1=CC=C(C)C=C13 IWVRVEIKCBFZNF-UHFFFAOYSA-N 0.000 title abstract 2
- 229950002220 pirlindole Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
La présente invention concerne un nouveau procédé d'obtention d'énantiomères de pirlindole optiquement actifs, sous forme d'une base libre ou sous forme de sels pharmaceutiquement acceptables. Les produits obtenus selon la présente invention sont énantiomériquement purs et sont utiles en médecine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PT2014/000027 WO2015171003A1 (fr) | 2014-05-09 | 2014-05-09 | Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39449A1 true MA39449A1 (fr) | 2017-11-30 |
Family
ID=50819929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39449A MA39449A1 (fr) | 2014-05-09 | 2014-05-09 | Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US9682986B2 (fr) |
| EP (1) | EP3140265B1 (fr) |
| JP (1) | JP6516769B2 (fr) |
| KR (1) | KR102258709B1 (fr) |
| CN (1) | CN106414376B (fr) |
| AU (1) | AU2014393488C1 (fr) |
| BR (1) | BR112016025918B1 (fr) |
| CA (1) | CA2948604C (fr) |
| CY (1) | CY1122367T1 (fr) |
| DK (1) | DK3140265T3 (fr) |
| EC (1) | ECSP16086217A (fr) |
| ES (1) | ES2753403T3 (fr) |
| HR (1) | HRP20192029T1 (fr) |
| HU (1) | HUE046437T2 (fr) |
| IL (1) | IL248853B (fr) |
| LT (1) | LT3140265T (fr) |
| MA (1) | MA39449A1 (fr) |
| MX (1) | MX357918B (fr) |
| NZ (1) | NZ726129A (fr) |
| PH (1) | PH12016502234A1 (fr) |
| PL (1) | PL3140265T3 (fr) |
| PT (1) | PT3140265T (fr) |
| RS (1) | RS59499B1 (fr) |
| RU (1) | RU2666731C2 (fr) |
| SA (1) | SA516380265B1 (fr) |
| SI (1) | SI3140265T1 (fr) |
| TN (1) | TN2016000496A1 (fr) |
| UA (1) | UA118696C2 (fr) |
| WO (1) | WO2015171003A1 (fr) |
| ZA (1) | ZA201607722B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ726127A (en) * | 2014-05-09 | 2019-03-29 | Tecnimede Sociedade Tecnico Medicinal S | Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine |
| US9682986B2 (en) | 2014-05-09 | 2017-06-20 | Tecnimede Sociedade Tecnico-Medicinal S.A. | Process for obtaining optically active pirlindole enantiomers and salts thereof |
| EP3392250A1 (fr) * | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole |
| EP3392251A1 (fr) | 2017-04-21 | 2018-10-24 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Procedé pour la préparation des enantiomères de pirlindole et leurs sels |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2281085C2 (ru) * | 2004-05-25 | 2006-08-10 | Закрытое акционерное общество "Мастерлек" | Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола |
| US9682986B2 (en) | 2014-05-09 | 2017-06-20 | Tecnimede Sociedade Tecnico-Medicinal S.A. | Process for obtaining optically active pirlindole enantiomers and salts thereof |
-
2014
- 2014-05-09 US US15/309,906 patent/US9682986B2/en active Active
- 2014-05-09 CA CA2948604A patent/CA2948604C/fr active Active
- 2014-05-09 DK DK14726442T patent/DK3140265T3/da active
- 2014-05-09 LT LT14726442T patent/LT3140265T/lt unknown
- 2014-05-09 BR BR112016025918-1A patent/BR112016025918B1/pt active IP Right Grant
- 2014-05-09 MX MX2016014703A patent/MX357918B/es active IP Right Grant
- 2014-05-09 MA MA39449A patent/MA39449A1/fr unknown
- 2014-05-09 RS RS20191433A patent/RS59499B1/sr unknown
- 2014-05-09 ES ES14726442T patent/ES2753403T3/es active Active
- 2014-05-09 SI SI201431386T patent/SI3140265T1/sl unknown
- 2014-05-09 TN TN2016000496A patent/TN2016000496A1/en unknown
- 2014-05-09 CN CN201480078731.6A patent/CN106414376B/zh active Active
- 2014-05-09 RU RU2016148181A patent/RU2666731C2/ru active
- 2014-05-09 EP EP14726442.8A patent/EP3140265B1/fr active Active
- 2014-05-09 HR HRP20192029TT patent/HRP20192029T1/hr unknown
- 2014-05-09 AU AU2014393488A patent/AU2014393488C1/en active Active
- 2014-05-09 PL PL14726442T patent/PL3140265T3/pl unknown
- 2014-05-09 HU HUE14726442A patent/HUE046437T2/hu unknown
- 2014-05-09 PT PT147264428T patent/PT3140265T/pt unknown
- 2014-05-09 NZ NZ726129A patent/NZ726129A/en unknown
- 2014-05-09 KR KR1020167031371A patent/KR102258709B1/ko active Active
- 2014-05-09 UA UAA201611334A patent/UA118696C2/uk unknown
- 2014-05-09 JP JP2016567540A patent/JP6516769B2/ja active Active
- 2014-05-09 WO PCT/PT2014/000027 patent/WO2015171003A1/fr not_active Ceased
-
2016
- 2016-11-09 ZA ZA2016/07722A patent/ZA201607722B/en unknown
- 2016-11-09 IL IL248853A patent/IL248853B/en active IP Right Grant
- 2016-11-09 EC ECIEPI201686217A patent/ECSP16086217A/es unknown
- 2016-11-09 SA SA516380265A patent/SA516380265B1/ar unknown
- 2016-11-09 PH PH12016502234A patent/PH12016502234A1/en unknown
-
2019
- 2019-11-13 CY CY20191101194T patent/CY1122367T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
| CY1121062T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου alzheimer | |
| CR20130629A (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
| GEAP201814248A (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| MX2019000536A (es) | Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1. | |
| MX2016010056A (es) | 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso. | |
| EA201790693A1 (ru) | Коррекция фигуры | |
| WO2014145205A3 (fr) | Procédés et compositions de modulateurs de la transcription de p27kip1 | |
| EP4249071A3 (fr) | Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton | |
| MX2016011105A (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos. | |
| MX2015001917A (es) | Composiciones farmaceuticas de memantina. | |
| EA201790315A1 (ru) | Модуляторы x-рецепторов печени | |
| TR201819805T4 (tr) | Flavaglin türevleri̇. | |
| PE20181296A1 (es) | Forma cristalina de 2-(2,6-diclorofenil)-1-[(1s,3r)-3-(hidroximetil)-5-(3-hidroxi-3-metilbutil)-1-metil-3,4-dihidroisoquinolin-2(1h)-il]etanona para el tratamiento de la enfermedad de parkinson | |
| CY1122367T1 (el) | Διαδικασια για την αποκτηση ενεργων οπτικα εναντιομερων πιρλινδολης και των αλατων τους | |
| PH12015502676A1 (en) | 4-(5-(4-chlorophenyl)-2-(2-cyclopropylacetyl)-1,4-dimethyl-1h-pyrrol-3-yl)benzenesulfonamide as alpha 7 nachr modulator | |
| EA201991286A1 (ru) | Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин | |
| PH12016502235A1 (en) | Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine | |
| TN2017000448A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease | |
| FR3028760B1 (fr) | Composition cosmetique de soin et/ou de maquillage de la peau | |
| PH12020500385A1 (en) | A process for preparation of triaminopyrimidine compound and intermediates thereof | |
| PH12019502792A1 (en) | Tetrahydropyridopyrazine modulators of gpr6 | |
| EP3492092A4 (fr) | Procédé de préparation d'un produit à base des feuilles de la plante sedum telephium pour traiter des ongles infectés par une onychomycose | |
| MX2016016895A (es) | Forma polimórfica novedosa del clorhidrato de n-[2-(6-fluoro-1h-indol-3-il)etil]-3-(2,2,3,3-tetrafluoropropoxi) bencilamina para el tratamiento de alzhéimer. | |
| PH12016502527B1 (en) | Stabilized desmopressin |